EP1922072A4 - Composes de piperazine specifiques du recepteur de la melanocortine avec groupes diamine - Google Patents

Composes de piperazine specifiques du recepteur de la melanocortine avec groupes diamine

Info

Publication number
EP1922072A4
EP1922072A4 EP06813393A EP06813393A EP1922072A4 EP 1922072 A4 EP1922072 A4 EP 1922072A4 EP 06813393 A EP06813393 A EP 06813393A EP 06813393 A EP06813393 A EP 06813393A EP 1922072 A4 EP1922072 A4 EP 1922072A4
Authority
EP
European Patent Office
Prior art keywords
melanocortin receptor
piperazine compounds
diamine groups
specific piperazine
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06813393A
Other languages
German (de)
English (en)
Other versions
EP1922072A2 (fr
Inventor
Shubh D Sharma
Yi-Qun Shi
Kevin Burris
Zhijun Wu
Papireddy Purma
Yadi Reddy Bonuga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palatin Technologies Inc
Original Assignee
Palatin Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palatin Technologies Inc filed Critical Palatin Technologies Inc
Publication of EP1922072A2 publication Critical patent/EP1922072A2/fr
Publication of EP1922072A4 publication Critical patent/EP1922072A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP06813393A 2005-08-11 2006-08-11 Composes de piperazine specifiques du recepteur de la melanocortine avec groupes diamine Withdrawn EP1922072A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70748805P 2005-08-11 2005-08-11
PCT/US2006/031472 WO2007021990A2 (fr) 2005-08-11 2006-08-11 Composes de piperazine specifiques du recepteur de la melanocortine avec groupes diamine

Publications (2)

Publication Number Publication Date
EP1922072A2 EP1922072A2 (fr) 2008-05-21
EP1922072A4 true EP1922072A4 (fr) 2010-12-29

Family

ID=37758229

Family Applications (2)

Application Number Title Priority Date Filing Date
EP06813393A Withdrawn EP1922072A4 (fr) 2005-08-11 2006-08-11 Composes de piperazine specifiques du recepteur de la melanocortine avec groupes diamine
EP06813394A Withdrawn EP1919479A4 (fr) 2005-08-11 2006-08-11 Composes de piperazine specifique du recepteur de la melanocortine et composes de ketopiperazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP06813394A Withdrawn EP1919479A4 (fr) 2005-08-11 2006-08-11 Composes de piperazine specifique du recepteur de la melanocortine et composes de ketopiperazine

Country Status (4)

Country Link
EP (2) EP1922072A4 (fr)
JP (2) JP2009504671A (fr)
CN (2) CN101272789A (fr)
WO (2) WO2007021990A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
CN101272789A (zh) * 2005-08-11 2008-09-24 帕拉坦技术公司 黑皮质素受体-特异性哌嗪和酮-哌嗪化合物
WO2008090357A2 (fr) * 2007-01-24 2008-07-31 Palatin Technologies, Inc. Composés à base de pipérazine spécifiques du récepteur de la mélanocortine
WO2009144432A1 (fr) * 2008-05-30 2009-12-03 Palatin Technologies, Inc. Agonistes de mc4-r pour le traitement de l'obésité
US10487072B2 (en) 2015-11-27 2019-11-26 Mitsubishi Tanabe Pharma Corporation Substituted imidazoles as melanocortin receptor agonists

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157264A1 (en) * 2001-08-10 2004-08-12 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US20050130988A1 (en) * 2001-08-10 2005-06-16 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7160886B2 (en) * 2003-03-03 2007-01-09 Merck & Co., Inc. Acylated piperazine derivatives as melanocortin-4 receptor agonists
CN101272789A (zh) * 2005-08-11 2008-09-24 帕拉坦技术公司 黑皮质素受体-特异性哌嗪和酮-哌嗪化合物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157264A1 (en) * 2001-08-10 2004-08-12 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US20050130988A1 (en) * 2001-08-10 2005-06-16 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule

Also Published As

Publication number Publication date
WO2007021990A2 (fr) 2007-02-22
WO2007021990A3 (fr) 2007-08-09
EP1919479A4 (fr) 2010-11-17
EP1922072A2 (fr) 2008-05-21
JP2009504672A (ja) 2009-02-05
WO2007021991A2 (fr) 2007-02-22
EP1919479A2 (fr) 2008-05-14
CN101272789A (zh) 2008-09-24
JP2009504671A (ja) 2009-02-05
CN101272788A (zh) 2008-09-24
WO2007021991A3 (fr) 2007-07-12

Similar Documents

Publication Publication Date Title
HUS2100054I1 (hu) Melanokortin receptor ligandumok
EP1872641A4 (fr) Structure en couches comprenant des elements imprimes
GB0519009D0 (en) Pocketted spring units
EP1835006A4 (fr) Élément électroluminescent organique
IL187395A0 (en) Laminated felt articles
GB0604191D0 (en) Unit arrangement
EP1881543A4 (fr) Element electroluminescent organique
EP1944527A4 (fr) Unite d' alimentation
GB0520115D0 (en) Ink-less printing
AU309753S (en) Media case
TWI319962B (en) Ionizer with parts-extension unit
EP1942006A4 (fr) Imprimante
EP1922072A4 (fr) Composes de piperazine specifiques du recepteur de la melanocortine avec groupes diamine
GB2432813B (en) Printer
EP1994209A4 (fr) Impression de petites molécules
EP1941573A4 (fr) Systemes d'alimentation en combustible presentant une resistance de fonctionnement
GB2428621B (en) Pinhead
GB0618962D0 (en) Printer
TWI369807B (en) Fuel supply systems having operational resistance
TWM291329U (en) Paint-dotting pen structure
GB0524468D0 (en) Spring units
PL372284A1 (pl) Element budowlany drewniano-metalowy
GB0506820D0 (en) Saddles
GB0523373D0 (en) Nidogen/snep-like molecule
AU307569S (en) Pen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1117062

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20101130

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 241/14 20060101ALI20101124BHEP

Ipc: A61P 15/10 20060101ALI20101124BHEP

Ipc: C07D 241/04 20060101ALI20101124BHEP

Ipc: A61K 31/496 20060101AFI20080318BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110301

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1117062

Country of ref document: HK